Navigation Links
Medicsight Launches ColonCAD(TM) Online CTC Platform
Date:6/29/2009

NEW YORK, June 29 /PRNewswire-FirstCall/ -- Medicsight PLC, a subsidiary of MGT Capital Investments, Inc. (NYSE AMEX: MGT) and an industry leader in the development of Computer-Aided Detection (CAD) and image analysis software that assists radiologists in the early detection of disease, is pleased to announce the launch of its online product, MedicRead(TM) 3.0 Colon. This online offering makes the benefits of Medicsight's ColonCAD software truly accessible to all radiologists for the first time.

MedicRead(TM) 3.0 Colon is Medicsight's advanced visualization platform that includes the Company's ColonCAD(TM) software. MedicRead(TM) 3.0 Colon allows radiologists to read computer tomography (CT) scans for the detection of colonic polyps, which may be the precursors of colon cancer. MedicRead(TM) 3.0 Colon can be downloaded from the Internet at www.medicsight.com and will be sold as a total solution with either a single list price or available on a monthly installment basis over 12 months.

Allan Rowley, Chief Executive of Medicsight, commented, "The launch of the online MedicRead 3.0 Colon platform provides us with an additional distribution channel for our exciting ColonCAD(TM) software. The MedicRead 3.0 Colon platform is currently the only visualization workstation for virtual colonoscopy that can be accessed and downloaded via the Internet. This broad access allows us to reach a broader user base and allows the international radiology community the ability to take advantage of the clinical benefits of our ColonCAD."

Access to Medicsight's ColonCAD(TM) software is currently available through its partners' advanced 3D visualization platforms. As part of Medicsight's ongoing commitment to radiologists and to improving the early detection of colorectal cancer, Medicsight has developed MedicRead 3.0 Colon. This is a competitively priced, standalone, CTC visualization workstation that incorporates the latest version of ColonCAD 4.0 as well as Medicsight's MedicServer(TM) technology. MedicRead 3.0 Colon offers a valuable centralized pre-processing platform that accepts DICOM CT image data from either the CT console or any PACS system.

A 30-day free trial version of the software can be downloaded from the Medicsight new website www.medicsight.com, allowing radiologists to experience the benefits of ColonCAD first-hand.

The new online application was showcased at the Medicsight booth at ESGAR 2009, which took place last week in Valencia, Spain.

Medicsight's ColonCAD technology has been approved for use in the European Union, China, Canada and Brazil. MedicRead 3.0 Colon is not currently available for sale in the United States.

About MGT Capital Investments, Inc.

MGT Capital Investments, Inc. is a technology holding company that focuses on investments in the global healthcare information technology market. The Company has two subsidiaries, Medicsight PLC and Medicexchange Ltd.

Medicsight PLC (AIM: MDST) is a UK-headquartered, research driven, leading developer of computer-aided detection (CAD) and image analysis software for the medical imaging market. The CAD software automatically highlights suspicious areas on computerized tomography (CT) scans of the colon and lung, helping radiologists to identify, measure and analyze potential disease and early indicators of disease. Medicsight's CAD software has been validated using one of the world's largest and most population diverse databases of verified patient CT scan data. Medicsight's ColonCAD(TM) and LungCAD(TM) software products are seamlessly integrated with the advanced 3D visualization workstations of several industry-leading imaging equipment partners.

Medicexchange Ltd. provides medical imaging professionals with a global web portal containing an online sales, jobs and information channel for diagnostic, treatment and surgery planning solutions. This combined with a variety of relevant clinical papers, training materials and content gives these professionals access to information and products that they otherwise would have difficulty accessing.

Additional information can be found at www.mgtci.com.

All forward-looking statements are made pursuant to the 'safe harbor' provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are based on current management expectations that involve risks and uncertainties that may result in such expectations not being realized. Potential risks and uncertainties include, but are not limited to, the risks described in company filings with the Securities and Exchange Commission.


'/>"/>
SOURCE MGT Capital Investments, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Medicsight Announces Global Agreement With Alma IT Systems
2. CMS Decision - No Material Financial Impact to Medicsight
3. Medicsight PLC Provides Business Update
4. Medicsight PLC Restructures Management Team
5. MGT Capital Investments, Inc.: Failure to Satisfy a Continued Listing Rule Based on a Lack of Shareholder Meeting in 2008 and Medicsight Statement Regarding CMS Proposed Decision
6. Medicsight PLC Receives Additional Information Request for FDA 510(k) Clearance
7. Medicsight PLC Presents New Data at RSNA 2008 Further Supporting Relevance of Computer-Aided Detection (CAD) and Image Analysis Software in Early Colon Cancer Screening and Diagnosis
8. Medicsight Announces New Global Marketing Partnership with Ziosoft Unveiled at RSNA 2008
9. Medicsight ColonCAD Technology Successfully Identified Cancer in 100% of Patients Included in Data Presented at ESGAR 2008
10. Medicsight Announces Appointment of NM Rothschild & Sons Limited as Corporate Adviser
11. MGT Capital Investments, Inc. is Delighted with the Announcement of Medicsights Commercial Agreement with Toshiba PACS Division
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... ... ... Silicon Valley Hair Institute, the San Francisco Bay Area leader in women's ... loss. Although hair transplant procedures can be seen as more of a man’s issue, ... two reasons a woman may see her hair thinning. , “We are used to ...
(Date:3/28/2017)... ... March 28, 2017 , ... Bacteria and fungi are probably not the first ingredients that come ... including the right microorganisms in your diet can actually improve health outcomes. And the good ... is the topic of a new peer-reviewed paper led by Maria Marco, ...
(Date:3/27/2017)... ... March 27, 2017 , ... Drs. Justin Kolnick, Kara Diamond, ... teaching their patients about the key role this treatment plays in protecting oral health, ... endodontist. To better serve those who need a root canal in White Plains, NY ...
(Date:3/27/2017)... ... 27, 2017 , ... Buzzies parent company, The TouchPoint Solution’s CEO and co-founder, ... and UBS’ Project Entrepreneur. Mayo will present her pitch about the lifestyle wearable devices, ... second annual venture competition ignites bold ideas by providing women access to the tools, ...
(Date:3/27/2017)... ... March 27, 2017 , ... ... athletes. A type of groin injury, it occurs when the muscles around the ... pain in and around the lower torso, as well as accompanying tenderness and ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... 27, 2017 /PRNewswire/ - INVICTUS MD STRATEGIES CORP. ("Invictus ... Invictus MD is pleased to announce it has received ... on the TSX Venture Exchange.  Receiving ... year of significant achievements for Invictus-MD. Some of which ... at AB Laboratories Inc. ("AB Labs"), a Licensed Producer ...
(Date:3/27/2017)... YORK , March 27, 2017 ... colors as the NASDAQ Composite closed the trading session ... lower; and the S&P 500 was down 0.08%. US ... nine sectors finishing the day in green. Pre-market today, ... Wright Medical Group N.V. (NASDAQ: WMGI), Amedica Corporation (NASDAQ: ...
(Date:3/27/2017)... YORK , March 27, 2017 /PRNewswire/ ... technology platform for value-based precision medicine, today ... collaboration with Novartis Pharmaceuticals Corporation to help ... cancer patients. As part of ... previous announced collaboration entered into January 2016, ...
Breaking Medicine Technology: